Article
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.
The pharmacogenomics journal - 1 Dec 2013
Simon N, Marsot A, Villard E, Choquet S, Khe H-X, Zahr N, Lechat P, Leblond V, Hulot J-S
Abstract excerpt
Human multidrug resistance-related protein 2 (MRP2, encoded by ABCC2) is involved in the transport of anionic drugs such as methotrexate (MTX). We prospectively investigated the influence of four common ABCC2 genetic variants (rs717620, rs2273697, rs8187694 and rs8187710) on MTX pharmacokinetics parameters. MTX concentrations were monitored in 50 patients with lymphoid malignancy (27 males; mean age: 53±17 years)...
Read the complete abstract on PubMed